368 related articles for article (PubMed ID: 25915438)
1. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
[TBL] [Abstract][Full Text] [Related]
2. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
[TBL] [Abstract][Full Text] [Related]
3. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.
Azar P; Wood E; Nguyen P; Luma M; Montaner J; Kerr T; Milloy MJ
BMC Infect Dis; 2015 Apr; 15():193. PubMed ID: 25927573
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
[TBL] [Abstract][Full Text] [Related]
5. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
[TBL] [Abstract][Full Text] [Related]
6. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
[TBL] [Abstract][Full Text] [Related]
7. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
[TBL] [Abstract][Full Text] [Related]
9. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Antiretroviral Adherence Self-efficacy Among People Living With HIV/AIDS in a Canadian Setting.
Lee WK; Milloy MJS; Nosova E; Walsh J; Kerr T
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):103-109. PubMed ID: 30300214
[TBL] [Abstract][Full Text] [Related]
11. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
Loh J; Kennedy MC; Wood E; Kerr T; Marshall B; Parashar S; Montaner J; Milloy MJ
AIDS Care; 2016 Nov; 28(11):1448-54. PubMed ID: 27248328
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.
Lee WK; Milloy MJ; Walsh J; Nguyen P; Wood E; Kerr T
Health Psychol; 2016 Mar; 35(3):290-7. PubMed ID: 26690643
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
Richardson LA; Kerr TH; Dobrer S; Puskas CM; Guillemi SA; Montaner JS; Wood E; Milloy MJ
AIDS; 2015 Nov; 29(18):2487-95. PubMed ID: 26558546
[TBL] [Abstract][Full Text] [Related]
15. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
16. Material security and adherence to antiretroviral therapy among HIV-positive people who use illicit drugs.
Mohd Salleh NA; Van Draanen J; Nosova E; Barrios R; Milloy MJ; Richardson L
AIDS; 2020 Jun; 34(7):1037-1045. PubMed ID: 32073444
[TBL] [Abstract][Full Text] [Related]
17. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.
Slawson G; Milloy MJ; Balneaves L; Simo A; Guillemi S; Hogg R; Montaner J; Wood E; Kerr T
AIDS Behav; 2015 Jan; 19(1):120-7. PubMed ID: 25012624
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Antiretroviral Therapy Among Incarcerated Persons with HIV: Associations with Methadone and Perceived Safety.
Culbert GJ; Waluyo A; Wang M; Putri TA; Bazazi AR; Altice FL
AIDS Behav; 2019 Aug; 23(8):2048-2058. PubMed ID: 30465106
[TBL] [Abstract][Full Text] [Related]
19. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
[TBL] [Abstract][Full Text] [Related]
20. Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.
Ickowicz S; Salleh NAM; Fairbairn N; Richardson L; Small W; Milloy MJ
AIDS Behav; 2019 Sep; 23(9):2634-2639. PubMed ID: 31236749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
